Our portfolio includes investments across all emerging disciplines, such as autonomous systems/AI, quantum technology, mobility, sustainable energy, genomics, synthetic biology, life sciences, and blockchain. This leads to a diversified portfolio of companies with category-creating potential.
Professor Mikhail Shapiro. Ultrasound-enabled drug discovery.
Professor J. Campbell & B. Stoltz. Novel cancer therapeutics targeting DNA repair and replication.
Professor Ali Hajimiri. Hybrid electronic, photonic technology.
Professor Kimberly See. Sustainable energy storage from abundant eco-materials.
Tony Zhang, PhD. Superhuman reasoning of the physical world.
Professor Viviana Gradinaru. Neuroscience target discovery.
Professor Michael Elowitz. Synthetic Biology inspired therapeutics.